Organon (OGN) Shares Outstanding (Diluted Average) (2020 - 2025)
Organon has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $260.8 million for Q4 2025.
- Quarterly results put Shares Outstanding (Diluted Average) at $260.8 million for Q4 2025, up 0.62% from a year ago — trailing twelve months through Dec 2025 was $260.8 million (up 0.62% YoY), and the annual figure for FY2025 was $260.8 million, up 0.62%.
- Shares Outstanding (Diluted Average) for Q4 2025 was $260.8 million at Organon, roughly flat from $260.6 million in the prior quarter.
- Over the last five years, Shares Outstanding (Diluted Average) for OGN hit a ceiling of $261.0 million in Q1 2025 and a floor of $253.5 million in Q1 2021.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $256.2 million (2023), compared with a mean of $256.9 million.
- Biggest five-year swings in Shares Outstanding (Diluted Average): changed 0.0% in 2021 and later rose 1.12% in 2024.
- Organon's Shares Outstanding (Diluted Average) stood at $254.2 million in 2021, then increased by 0.38% to $255.2 million in 2022, then grew by 0.43% to $256.3 million in 2023, then rose by 1.12% to $259.2 million in 2024, then increased by 0.62% to $260.8 million in 2025.
- The last three reported values for Shares Outstanding (Diluted Average) were $260.8 million (Q4 2025), $260.6 million (Q3 2025), and $260.6 million (Q2 2025) per Business Quant data.